Latest papers

Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene.

[Combined fat products modern approaches to quality assessment].

Modern, new pharmacotherapy for obesity. A gastrointestinal approach.

Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men.

[Medium-chain triglyceride fats are not suited for long-term weight loss: DGE explains the role of medium-chain fats].

Atkins world.

Phytosterol additives increase blood pressure and promote stroke onset in salt-loaded stroke-prone spontaneously hypertensive rats.

Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole' Study.

Is olestra consumption associated with changes in dietary intake, serum lipids, and body weight?

Olestra: targetless arrow?

Health risks, past usage, and intention to use weight loss products in normal weight women with high and low body dysphoria.

Intestinal alkaline phosphatase release is not associated with chylomicron formation.

Integration of orosensory and postingestive stimuli for the control of excessive fat intake in mice.

Modifications in cyclosporine (CsA) microemulsion blood concentrations by olestra.

Olestra labeling change.

A 9-mo randomized clinical trial comparing fat-substituted and fat-reduced diets in healthy obese men: the Ole Study.

Moisture retention and consumer acceptability of chocolate bar cookies prepared with okra gum as a fat ingredient substitute.

Reduced fat is not equal to low calorie.

Fat substitutes and health: an advisory from the Nutrition Committee of the American Heart Association.

Effect on body weight of replacing dietary fat with olestra for two or ten weeks in healthy men and women.